JCR Pharmaceuticals Co., Ltd. (JCRRF)
JCRRF Stock Price Chart
Explore JCR Pharmaceuticals Co., Ltd. interactive price chart. Choose custom timeframes to analyze JCRRF price movements and trends.
JCRRF Company Profile
Discover essential business fundamentals and corporate details for JCR Pharmaceuticals Co., Ltd. (JCRRF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
29 Jan 2021
Employees
934.00
Website
https://www.jcrpharm.co.jpCEO
Shin Ashida
Description
JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.
JCRRF Financial Timeline
Browse a chronological timeline of JCR Pharmaceuticals Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Oct 2025
Revenue estimate is $76.69M.
Earnings released on 30 Jul 2025
EPS came in at -$0.03 falling short of the estimated $0.03 by -202.78%, while revenue for the quarter reached $59.46M , missing expectations by -22.47%.
Earnings released on 13 May 2025
EPS came in at -$0.23 surpassing the estimated -$0.36 by +37.06%, while revenue for the quarter reached $47.94M , beating expectations by +0.63%.
Dividend declared on 13 May 2025
A dividend of $0.07 per share was announced, adjusted to $0.07.
Dividend declared on 13 May 2025
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend will be paid on 1 Dec 2025.
Earnings released on 31 Jan 2025
EPS came in at $0.01 falling short of the estimated $0.07 by -91.95%, while revenue for the quarter reached $58.66M , missing expectations by -10.71%.
Earnings released on 30 Oct 2024
EPS came in at -$0.05 falling short of the estimated $0.10 by -152.04%, while revenue for the quarter reached $59.22M , missing expectations by -24.38%.
Earnings released on 29 Sept 2024
EPS came in at -$0.05 falling short of the estimated $0.09 by -157.69%, while revenue for the quarter reached $59.61M , missing expectations by -12.24%.
Earnings released on 30 Jul 2024
EPS came in at $0.01 falling short of the estimated $0.05 by -81.05%, while revenue for the quarter reached $50.60M , missing expectations by -20.24%.
Earnings released on 30 Jun 2024
EPS came in at $0.01 falling short of the estimated $0.05 by -80.87%, while revenue for the quarter reached $50.71M , missing expectations by -14.03%.
Earnings released on 10 May 2024
Dividend declared on 10 May 2024
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 26 Jun 2025.
Dividend declared on 10 May 2024
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 6 Dec 2024.
Earnings released on 31 Mar 2024
EPS came in at $0.02 falling short of the estimated $0.05 by -64.38%, while revenue for the quarter reached $60.34M , beating expectations by +4.89%.
Earnings released on 26 Jan 2024
EPS came in at -$0.01 falling short of the estimated $0.03 by -121.26%, while revenue for the quarter reached $66.94M , beating expectations by +14.62%.
Dividend declared on 11 May 2023
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 27 Jun 2024.
Dividend declared on 11 May 2023
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 8 Dec 2023.
Earnings released on 31 Jan 2023
EPS came in at $0.16 surpassing the estimated $0.00 by +3.51K%, while revenue for the quarter reached $67.52M , beating expectations by +11.67%.
Earnings released on 26 Oct 2022
EPS came in at -$0.02 falling short of the estimated -$0.00 by -3.28K%, while revenue for the quarter reached $90.10M , beating expectations by +60.58%.
Earnings released on 27 Jul 2022
EPS came in at $0.08 surpassing the estimated $0.01 by +990.32%, while revenue for the quarter reached $74.79M , beating expectations by +20.61%.
Earnings released on 12 May 2022
EPS came in at $0.10 falling short of the estimated $0.28 by -65.12%, while revenue for the quarter reached $57.71M , missing expectations by -52.17%.
Dividend declared on 12 May 2022
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 22 Jun 2023.
Dividend declared on 12 May 2022
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 9 Dec 2022.
Dividend declared on 30 Mar 2022
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 23 Jun 2022.
Earnings released on 27 Jan 2022
EPS came in at $0.26 surpassing the estimated $0.21 by +24.39%, while revenue for the quarter reached $85.69M , beating expectations by +0.53%.
Earnings released on 28 Oct 2021
EPS came in at $0.55 surpassing the estimated $0.21 by +160.10%, while revenue for the quarter reached $41.32M .
Earnings released on 29 Jul 2021
EPS came in at $0.11 falling short of the estimated $0.25 by -54.51%, while revenue for the quarter reached $70.67M .
Earnings released on 13 May 2021
EPS came in at $0.27 surpassing the estimated $0.18 by +47.53%, while revenue for the quarter reached $88.42M .
Dividend declared on 13 May 2021
A dividend of $0.09 per share was announced, adjusted to $0.09. The dividend was paid on 10 Dec 2021.
Dividend declared on 30 Mar 2021
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 24 Jun 2021.
Earnings released on 28 Jan 2021
EPS came in at $0.16 , while revenue for the quarter reached $103.35M .
Earnings released on 26 Oct 2020
EPS came in at $0.04 , while revenue for the quarter reached $166.72M .
Dividend declared on 12 May 2020
A dividend of $0.17 per share was announced, adjusted to $0.04. The dividend was paid on 10 Dec 2020.
JCRRF Stock Performance
Access detailed JCRRF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.